Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients

Scand J Rheumatol. 1991;20(1):52-7. doi: 10.3109/03009749109165922.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / physiopathology
  • Dose-Response Relationship, Drug
  • Haptoglobins / analysis
  • Hemoglobins / analysis
  • Hemolysis*
  • Hemopexin / analysis
  • Humans
  • Sulfasalazine / adverse effects*
  • Sulfasalazine / therapeutic use

Substances

  • Haptoglobins
  • Hemoglobins
  • Sulfasalazine
  • Hemopexin